PSYD_2401: ZURICH

<i>This record is part of the Psy-ShareD database. The Psy-ShareD database will host pre-existing structural MRI data collected at different global sites that will be suitable for region of interest, voxel-based morphometry, cortical thickness and surface area analytical approaches. To access this database, complete the Data Access Request Form by following the link on this page under the Licence ‘Psy-ShareD Data Access Request’. For more information, follow the link listed in Related Materials.</i><b>Title: </b><b>C</b><b>ross-Sectional</b><b> Study of Individuals with ICD - 10 Schizophrenia</b><b>Contributors and PI’s:</b> Philipp Homan MD PhD, Giacomo Cecere MD, Wolfgang Omlor MD PhD, Akhil Ratan Misra, Pierfrancesco Sarti, Roya Melanie Hüppi, Werner Surbeck MD PhDPsychiatric Hospital, University of Zurich, Zurich, Switzerland<br><b>Key Details &amp; Variables</b><pre></pre><b>Age Range</b>17-39<b>Number of Participants</b>119<b>Diagnostic Criteria</b>ICD-10, SCZ<b>Number of Clinical Subjects</b>40<b>Number of Clinical Subjects (follow-up)</b>No<b>Number of Control Subjects</b>79<b>Number of Control Subjects (follow-up)</b>No<b>Demographic Information</b>Age, Sex, Education, Employment, Ethnicity<b>Clinical Measures</b>OLIFE, MSS, PANSS<b>Cognitive Measures</b>N/A<b>Clinical Functioning Measures</b>N/A<b>Antipsychotic Medication Information Recorded</b>Yes<b>Antipsychotic Medication Name/ Antipsychotic Type</b>N/A<b>Antipsychotic Dose Recorded</b>N/A<b>CPZ Equivalents Recorded</b>N/A<b>Other Medication Variables Recorded</b>No<b>Recreational Drug/ Alcohol Use</b>No<br>

<b>本记录隶属于Psy-ShareD数据库。该数据库将收录来自全球多个采集点的现有结构性磁共振成像（structural MRI）数据，此类数据适用于感兴趣区（region of interest）、基于体素的形态测量学、皮层厚度及表面积等分析方法。如需使用该数据库，请点击本页面中"Psy-ShareD数据使用申请"许可项下的链接，填写《数据使用申请表》。如需了解更多信息，请点击"相关资料"中列出的链接。</b><br><b>标题：</b><b>ICD-10精神分裂症患者横断面研究</b><br><b>贡献者与项目负责人：</b>Philipp Homan医学博士、哲学博士，Giacomo Cecere医学博士，Wolfgang Omlor医学博士、哲学博士，Akhil Ratan Misra，Pierfrancesco Sarti，Roya Melanie Hüppi，Werner Surbeck医学博士、哲学博士（瑞士苏黎世大学精神病医院，苏黎世）<br><b>核心详情与变量</b><pre></pre><br><b>年龄范围</b>17-39岁<br><b>参与者总数</b>119名<br><b>诊断标准</b>ICD-10、精神分裂症（SCZ）<br><b>临床受试者数量</b>40名<br><b>临床受试者（随访组）数量</b>无<br><b>对照受试者数量</b>79名<br><b>对照受试者（随访组）数量</b>无<br><b>人口统计学信息</b>年龄、性别、受教育程度、职业、种族<br><b>临床测评工具</b>OLIFE、MSS、PANSS<br><b>认知测评</b>无（N/A）<br><b>临床功能测评</b>无（N/A）<br><b>抗精神病药物信息记录情况</b>是<br><b>抗精神病药物名称/类型</b>无（N/A）<br><b>抗精神病药物剂量记录情况</b>无（N/A）<br><b>氯丙嗪等效剂量记录情况</b>无（N/A）<br><b>其他药物相关变量记录情况</b>无<br><b>娱乐性药物与酒精使用情况</b>无